Go Pro
→ Labor Day Warning: The secret that called 1929 is flashing something new (From Weiss Ratings) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
$0.00
$0.00
▼
$0.00
$4K0.8510,785 shs4 shs
Hudson Executive Investment Corp. stock logo
HEC
Hudson Executive Investment
$5.16
$8.58
$7.82
▼
$12.45
$213.62MN/A1.42 million shs2.17 million shs
InMode Ltd. stock logo
INMD
InMode
$14.91
+0.5%		$15.06
$12.72
▼
$16.74
$857.04M1.86433,998 shs213,084 shs
UPHL
UpHealth
$0.00
-66.7%		$0.00
$0.00
▼
$0.01
$2K0.333,141 shs850 shs
7 Best Space Stocks to Own in 2026 Cover
7 Best Space Stocks to Own in 2026

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
0.00%0.00%0.00%0.00%0.00%
Hudson Executive Investment Corp. stock logo
HEC
Hudson Executive Investment
0.00%0.00%0.00%0.00%+94.72%
InMode Ltd. stock logo
INMD
InMode
0.00%+0.40%-1.39%+10.12%+2.76%
UPHL
UpHealth
0.00%-66.67%0.00%0.00%-50.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
$0.00
$0.00
▼
$0.00
$4K0.8510,785 shs4 shs
Hudson Executive Investment Corp. stock logo
HEC
Hudson Executive Investment
$5.16
$8.58
$7.82
▼
$12.45
$213.62MN/A1.42 million shs2.17 million shs
InMode Ltd. stock logo
INMD
InMode
$14.91
+0.5%		$15.06
$12.72
▼
$16.74
$857.04M1.86433,998 shs213,084 shs
UPHL
UpHealth
$0.00
-66.7%		$0.00
$0.00
▼
$0.01
$2K0.333,141 shs850 shs
7 Best Space Stocks to Own in 2026 Cover
7 Best Space Stocks to Own in 2026

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
0.00%0.00%0.00%0.00%0.00%
Hudson Executive Investment Corp. stock logo
HEC
Hudson Executive Investment
0.00%0.00%0.00%0.00%+94.72%
InMode Ltd. stock logo
INMD
InMode
0.00%+0.40%-1.39%+10.12%+2.76%
UPHL
UpHealth
0.00%-66.67%0.00%0.00%-50.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
0.00
N/AN/AN/A
Hudson Executive Investment Corp. stock logo
HEC
Hudson Executive Investment
0.00
N/AN/AN/A
InMode Ltd. stock logo
INMD
InMode
2.00
Hold$16.007.31% Upside
UPHL
UpHealth
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest HEC, UPHL, BTTX, and INMD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/6/2026
InMode Ltd. stock logo
INMD
InMode
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D+)
(Data available from 9/6/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
N/AN/AN/AN/AN/AN/A
Hudson Executive Investment Corp. stock logo
HEC
Hudson Executive Investment
N/AN/AN/AN/A$0.12 per shareN/A
InMode Ltd. stock logo
INMD
InMode
$374.63M2.29$1.49 per share9.99$10.94 per share1.36
UPHL
UpHealth
$130M0.00N/AN/A$3.10 per share0.00
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
-$39.76M-$0.39N/AN/AN/AN/AN/AN/A11/12/2026 (Estimated)
Hudson Executive Investment Corp. stock logo
HEC
Hudson Executive Investment
-$27.24MN/AN/AN/AN/AN/A-337.48%-4.06%N/A
InMode Ltd. stock logo
INMD
InMode
$93.83M$1.2312.12N/AN/A20.69%11.99%10.60%10/28/2026 (Estimated)
UPHL
UpHealth
-$56.42M$1.98N/AN/AN/AN/AN/AN/AN/A

Latest HEC, UPHL, BTTX, and INMD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/5/2026Q2 2026
InMode Ltd. stock logo
INMD
InMode
$0.3460$0.35+$0.0040$0.29$94.89 million$95.59 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
N/AN/AN/AN/AN/A
Hudson Executive Investment Corp. stock logo
HEC
Hudson Executive Investment
N/AN/AN/AN/AN/A
InMode Ltd. stock logo
INMD
InMode
N/AN/AN/AN/AN/A
UPHL
UpHealth
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
N/AN/AN/A
Hudson Executive Investment Corp. stock logo
HEC
Hudson Executive Investment
N/A
0.33
0.33
InMode Ltd. stock logo
INMD
InMode
N/A
8.18
7.28
UPHL
UpHealth
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
34.00%
Hudson Executive Investment Corp. stock logo
HEC
Hudson Executive Investment
73.41%
InMode Ltd. stock logo
INMD
InMode
68.04%
UPHL
UpHealth
56.10%

Insider Ownership

CompanyInsider Ownership
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
51.40%
Hudson Executive Investment Corp. stock logo
HEC
Hudson Executive Investment
N/A
InMode Ltd. stock logo
INMD
InMode
6.92%
UPHL
UpHealth
34.24%
CompanyEmployeesShares OutstandingFree FloatOptionable
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
4040.58 million24.23 millionNo Data
Hudson Executive Investment Corp. stock logo
HEC
Hudson Executive Investment
N/A41.40 millionN/ANot Optionable
InMode Ltd. stock logo
INMD
InMode
48057.48 million53.50 millionOptionable
UPHL
UpHealth
1,75018.93 million12.45 millionNo Data

Recent News About These Companies

UpHealth Delays Latest Quarterly SEC Filing
August 14, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/uphealth-delays-latest-quarterly-sec-filing-2?utm_source=marketbeat.com&utm_medium=referral
UpHealth Delays Latest Quarterly SEC Filing
May 15, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/uphealth-delays-latest-quarterly-sec-filing?utm_source=marketbeat.com&utm_medium=referral
UpHealth Inc.
May 14, 2026  |  marketwatch.comhttps://www.marketwatch.com/investing/stock/UPHL/financials/secfilings
UpHealth Delays Q2 2025 10-Q Filing
August 14, 2025  |  msn.comhttps://www.msn.com/en-us/money/topstocks/uphealth-delays-q2-2025-10-q-filing/ar-AA1KyiKu
UpHealth, Inc. (UPHL) Latest Stock News & Headlines - Yahoo Finance
April 23, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/quote/UPHL/news/
Lemon Dump Cake Recipe
September 9, 2024  |  msn.comhttps://www.msn.com/en-us/foodanddrink/recipes/lemon-dump-cake-recipe/ar-AA10upHl
DJUSIV Dow Jones US Business Support Services Index
July 27, 2024  |  seekingalpha.comhttps://seekingalpha.com/symbol/DJUSIV
UpHealth Inc Ordinary Shares UPHL
July 19, 2024  |  morningstar.comM
UpHealth Holdings, Inc. Wins Ruling in Calcutta High Court, Mandating All Glocal Healthcare Respondents Submit Affidavits of Assets
May 24, 2024  |  prnewswire.comhttps://www.prnewswire.com/news-releases/uphealth-holdings-inc-wins-ruling-in-calcutta-high-court-mandating-all-glocal-healthcare-respondents-submit-affidavits-of-assets-302155289.html
UpHealth, Inc. (UPHL) Advances While Market Declines: Some Information for Investors
April 30, 2024  |  zacks.comhttps://www.zacks.com/stock/news/2265473/uphealth-inc-uphl-advances-while-market-declines-some-information-for-investors?cid=cs-stocknewsapi-ft-tale_of_the_tape|yseop_template_6v1-2265473
UpHealth, Inc. (UPHL)
April 17, 2024  |  finance.yahoo.comhttps://finance.yahoo.com/quote/UPHL/company-insights/
Calcutta High Court rules in favour of UpHealth Holdings, Inc., and vigorously reinforces the ICC International Court of Arbitration previous $110 million award against Glocal directors and other Respondents, calling their conduct “dishonest and fraudulent”
April 16, 2024  |  finance.yahoo.comhttps://finance.yahoo.com/news/calcutta-high-court-rules-favour-132000323.html?.tsrc=rss
UpHealth Holdings Takes Steps to Enforce the International Court of Arbitration’s Final Award to UpHealth Holdings of more than $110 Million in Damages in Breach of Contract Lawsuit Involving the 2020 Purchase by UpHealth of Glocal Healthcare Systems
April 1, 2024  |  finance.yahoo.comhttps://finance.yahoo.com/news/uphealth-holdings-takes-steps-enforce-124500323.html?.tsrc=rss
UpHealth, Inc.: UpHealth Provides Corporate Update and Announces Fourth Quarter and Full Year 2023 Financial Results
March 22, 2024  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2024-03/61755432-uphealth-inc-uphealth-provides-corporate-update-and-announces-fourth-quarter-and-full-year-2023-financial-results-399.htm
UpHealth Provides Corporate Update and Announces Fourth Quarter and Full Year 2023 Financial Results
March 21, 2024  |  finance.yahoo.comhttps://finance.yahoo.com/news/uphealth-provides-corporate-announces-fourth-203000690.html
Healthcare Triangle GAAP EPS of -$1.26, revenue of $7.1M
March 18, 2024  |  msn.comhttps://www.msn.com/en-us/money/savingandinvesting/healthcare-triangle-gaap-eps-of-126-revenue-of-71m/ar-BB1k4bVQ

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Bloom Energy logo overlaid on a row of fuel cell units at an outdoor installation site during sunset.
Bloom Energy’s AI Surge Meets a Valuation Reality Check
By Peter Frank | August 19, 2026
A Tesla electric vehicle with a sleek, futuristic design parked on a city street at night.
Tesla's Robotaxi Reality Check: Time to Deliver
By Jeffrey Neal Johnson | August 12, 2026
Ryman Hospitality Properties, Inc. logo overlaid on an aerial dusk view of downtown Nashville with the Ryman Auditorium and Gaylord Opryland.
Ryman Checks Into a $1.38B Hospitality Upgrade
By Jeffrey Neal Johnson | August 13, 2026
Glowing orange Bitcoin “₿” icon beside black “Strategy” lettering on a frosted glass office wall sign.
Strategy’s $1.59B Gamble: Checkmate at $80K?
By Jeffrey Neal Johnson | August 27, 2026
Qualcomm logo displayed on a computer chip mounted on an illuminated blue circuit board.
Qualcomm’s AI Ambitions Run Into a Smartphone Reality Check
By Nathan Reiff | September 1, 2026
Better Therapeutics stock logo

Better Therapeutics NASDAQ:BTTX

Better Therapeutics, Inc., a prescription digital therapeutics company, develops a form of cognitive behavioral therapy to address the causes of cardiometabolic diseases. The company's lead product candidate is BT-001, an investigational PDT platform to treat type 2 diabetes. It also develops software-based prescription digital therapeutics platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions. In addition, the company's clinical development candidates are intended to treat cardiometabolic diseases, including type 2 diabetes, hypertension, hyperlipidemia, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, and chronic kidney disease. Its product pipeline also includes BT-002, which intends glycemic control for hypertension; BT-003 to reduce LDL cholesterol in patients with hyperlipidemia; and BT-004, which intends to explore the impact of treatment on liver health in patients with non-alcoholic steatohepatitis/non-alcoholic fatty liver disease. The company was founded in 2015 and is headquartered in San Francisco, California.

Hudson Executive Investment stock logo

Hudson Executive Investment NASDAQ:HEC

Hudson Executive Investment Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.

InMode stock logo

InMode NASDAQ:INMD

$14.91 +0.07 (+0.47%)
As of 09/4/2026 04:00 PM Eastern

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.

UpHealth NYSE:UPHL

$0.0001 0.00 (-66.67%)
As of 09/4/2026 09:30 AM Eastern

UpHealth, Inc. provides behavioral health solutions through the utilization of evidence-based treatments and services in the Americas. The company offers mental health and substance use disorder treatment services directly to consumers. It also provides detoxification, residential, partial hospitalization program, intensive outpatient program, outpatient services, and non-clinical recovery residence and supporting housing services. UpHealth, Inc. is headquartered in Delray Beach, Florida.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas